Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffrey D. Johnson is active.

Publication


Featured researches published by Jeffrey D. Johnson.


Nature | 2010

Rfx6 directs islet formation and insulin production in mice and humans

Stuart Smith; Hui Qi Qu; Nadine Taleb; Nina Kishimoto; David W. Scheel; Yang Lu; Ann Marie Patch; Rosemary Grabs; Juehu Wang; Francis C. Lynn; Takeshi Miyatsuka; John Mitchell; Rina Seerke; Julie Désir; Serge Vanden Eijnden; Marc Abramowicz; Nadine Kacet; Jacques Weill; Marie Éve Renard; Mattia Gentile; Inger Hansen; Ken Dewar; Andrew T. Hattersley; Rennian Wang; Maria E. Wilson; Jeffrey D. Johnson; Constantin Polychronakos; Michael S. German

Insulin from the β-cells of the pancreatic islets of Langerhans controls energy homeostasis in vertebrates, and its deficiency causes diabetes mellitus. During embryonic development, the transcription factor neurogenin 3 (Neurog3) initiates the differentiation of the β-cells and other islet cell types from pancreatic endoderm, but the genetic program that subsequently completes this differentiation remains incompletely understood. Here we show that the transcription factor Rfx6 directs islet cell differentiation downstream of Neurog3. Mice lacking Rfx6 failed to generate any of the normal islet cell types except for pancreatic-polypeptide-producing cells. In human infants with a similar autosomal recessive syndrome of neonatal diabetes, genetic mapping and subsequent sequencing identified mutations in the human RFX6 gene. These studies demonstrate a unique position for Rfx6 in the hierarchy of factors that coordinate pancreatic islet development in both mice and humans. Rfx6 could prove useful in efforts to generate β-cells for patients with diabetes.


Molecular and Cellular Biology | 2000

The Homeodomain of PDX-1 Mediates Multiple Protein-Protein Interactions in the Formation of a Transcriptional Activation Complex on the Insulin Promoter

Kinuko Ohneda; Raghavendra G. Mirmira; Juehu Wang; Jeffrey D. Johnson; Michael S. German

ABSTRACT Activation of insulin gene transcription specifically in the pancreatic β cells depends on multiple nuclear proteins that interact with each other and with sequences on the insulin gene promoter to build a transcriptional activation complex. The homeodomain protein PDX-1 exemplifies such interactions by binding to the A3/4 region of the rat insulin I promoter and activating insulin gene transcription by cooperating with the basic-helix-loop-helix (bHLH) protein E47/Pan1, which binds to the adjacent E2 site. The present study provides evidence that the homeodomain of PDX-1 acts as a protein-protein interaction domain to recruit multiple proteins, including E47/Pan1, BETA2/NeuroD1, and high-mobility group protein I(Y), to an activation complex on the E2A3/4 minienhancer. The transcriptional activity of this complex results from the clustering of multiple activation domains capable of interacting with coactivators and the basal transcriptional machinery. These interactions are not common to all homeodomain proteins: the LIM homeodomain protein Lmx1.1 can also activate the E2A3/4 minienhancer in cooperation with E47/Pan1 but does so through different interactions. Cooperation between Lmx1.1 and E47/Pan1 results not only in the aggregation of multiple activation domains but also in the unmasking of a potent activation domain on E47/Pan1 that is normally silent in non-β cells. While more than one activation complex may be capable of activating insulin gene transcription through the E2A3/4 minienhancer, each is dependent on multiple specific interactions among a unique set of nuclear proteins.


Molecular and Cellular Biology | 1997

Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity.

Jeffrey D. Johnson; W Zhang; A. Rudnick; William J. Rutter; Michael S. German

LIM-homeodomain proteins direct cellular differentiation by activating transcription of cell-type-specific genes, but this activation requires cooperation with other nuclear factors. The LIM-homeodomain protein Lmx1 cooperates with the basic helix-loop-helix (bHLH) protein E47/Pan-1 to activate the insulin promoter in transfected fibroblasts. In this study, we show that two proteins originally called Lmx1 are the closely related products of two distinct vertebrate genes, Lmx1.1 and Lmx1.2. We have used yeast genetic systems to delineate the functional domains of the Lmx1 proteins and to characterize the physical interactions between Lmx1 proteins and E47/Pan-1 that produce synergistic transcriptional activation. The LIM domains of the Lmx1 proteins, and particularly the second LIM domain, mediate both specific physical interactions and transcriptional synergy with E47/Pan-1. The LIM domains of the LIM-homeodomain protein Isl-1, which cannot mediate transcriptional synergy with E47/Pan-1, do not interact with E47/Pan-1. In vitro studies demonstrate that the Lmx1.1 LIM2 domain interacts specifically with the bHLH domain of E47/Pan-1. These studies provide the basis for a model of the assembly of LIM-homeodomain-containing complexes on DNA elements that direct cell-type-restricted transcription in differentiated tissues.


Development | 2000

Expression of neurogenin3 reveals an islet cell precursor population in the pancreas

David W. Scheel; Jennifer R. Conners; J. Kalamaras; Jacqueline E. Lee; David J. Anderson; Lori Sussel; Jeffrey D. Johnson; Michael S. German


Archive | 2007

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Xin Chen; Peng Cheng; L. Edwards Clemens; Jeffrey D. Johnson; Jingyuan Ma; Alison Murphy; Imad Nashashibi; Christopher J. Rabbat; Jaingao Song; Maria E. Wilson; Yan Zhu; Zuchun Zhao


Archive | 2009

Oxymethylene aryl compounds and uses thereof

Maria E. Wilson; Jeffrey D. Johnson; L. Edward Clemens; Zuchun Zhao; Xin Chen


Diabetes | 2005

Matrix Metalloproteinases Contribute to Insulin Insufficiency in Zucker Diabetic Fatty Rats

Yun Ping Zhou; Azadeh Madjidi; Maria E. Wilson; David A. Nothhelfer; John H. “Wick” Johnson; John F. Palma; Anthony C. Schweitzer; Charles F. Burant; John E. Blume; Jeffrey D. Johnson


Archive | 2007

5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

Xin Chen; Peng Cheng; L. Edward Clemens; Jeffrey D. Johnson; Jingyuan Ma; Alison Murphy; Imad Nashashibi; Christoper J. Rabbat; Jiangao Song; Maria E. Wilson; Yan Zhu; Zuchun Zhao


Archive | 2002

Methods and reagents for diagnosis and treatment of diabetes

Jeffrey D. Johnson; John E. Blume; John F. Palma; Yun-Ping Zhou


Archive | 2009

2,4-disubsituted thiazoles and pharmaceutical compositions thereof

Xin Chen; Peng Cheng; L. Edward Clemens; Jeffrey D. Johnson; Jingyuan Ma; Alison Murphy; Imad Nashashibi; Christopher J. Rabbat; Jiangao Song; Maria E. Wilson; Yan Zhu; Zuchun Zhao

Collaboration


Dive into the Jeffrey D. Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juehu Wang

University of California

View shared research outputs
Top Co-Authors

Avatar

Francine M. Gregoire

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar

A. Rudnick

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge